These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15610929)

  • 1. Interactions between anxiety, social support, health status and buspirone efficacy in elderly patients.
    Majercsik E; Haller J
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1161-9. PubMed ID: 15610929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of social factors on the anxiolytic efficacy of buspirone in male rats, male mice, and men.
    Majercsik E; Haller J; Leveleki C; Baranyi J; Halász J; Rodgers RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Dec; 27(8):1187-99. PubMed ID: 14659474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and usefulness of buspirone as an anxiolytic drug in elderly versus young patients.
    Robinson D; Napoliello MJ; Schenk J
    Clin Ther; 1988; 10(6):740-6. PubMed ID: 3219687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buspirone and diazepam in anxiety: a controlled study.
    Rickels K; Weisman K; Norstad N; Singer M; Stoltz D; Brown A; Danton J
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):81-6. PubMed ID: 6130078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azapirones: an alternative to benzodiazepines for anxiety.
    Cadieux RJ
    Am Fam Physician; 1996 May; 53(7):2349-53. PubMed ID: 8638511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open trial of buspirone in the treatment of attention-deficit disorder.
    Niederhofer H
    Hum Psychopharmacol; 2003 Aug; 18(6):489-92. PubMed ID: 12923830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of glucocorticoids on the anxiolytic efficacy of buspirone.
    Haller J; Leveleki C; Halász J; Baranyi J; Makara GB
    Psychopharmacology (Berl); 2001 Oct; 157(4):388-94. PubMed ID: 11605098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of etifoxine compared to lorazepam monotherapy in the treatment of patients with adjustment disorders with anxiety: a double-blind controlled study in general practice.
    Nguyen N; Fakra E; Pradel V; Jouve E; Alquier C; Le Guern ME; Micallef J; Blin O
    Hum Psychopharmacol; 2006 Apr; 21(3):139-49. PubMed ID: 16625522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression and anxiety symptoms are associated with reduced dietary adherence in heart failure patients treated with an implantable cardioverter defibrillator.
    Luyster FS; Hughes JW; Gunstad J
    J Cardiovasc Nurs; 2009; 24(1):10-7. PubMed ID: 19114795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of attachment style, social support and the number of implantable cardioverter defibrillator (ICD) discharges on psychological strain of ICD patients].
    Simson U; Perings C; Plaskuda A; Schäfer R; Brehm M; Bader D; Tress W; Franz M
    Psychother Psychosom Med Psychol; 2006 Dec; 56(12):493-9. PubMed ID: 17160793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
    Arató M
    J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social instability in female rats: effects on anxiety and buspirone efficacy.
    Haller J; Baranyi J; Bakos N; Halász J
    Psychopharmacology (Berl); 2004 Jul; 174(2):197-202. PubMed ID: 14760513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety.
    Sramek JJ; Frackiewicz EJ; Cutler NR
    Clin Ther; 1997; 19(3):498-506. PubMed ID: 9220214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of neuropeptide Y in anxiety].
    Krysiak R; Obuchowicz E; Herman ZS
    Psychiatr Pol; 2001; 35(5):731-42. PubMed ID: 11842605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity.
    Mizuki Y; Suetsugi M; Ushijima I; Yamada M
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):291-300. PubMed ID: 7519702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.